AI Assistant
Blog
Pricing
Log In
Sign Up
294 Preclinical studies of TAC01-CLDN18.2, an autologous claudin 18.2-directed TAC T cell therapy, in the treatment of gastric cancer
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
